Dr. Patel is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
330 Brookline Ave / RW455
Boston, MA 02215Phone+1 617-667-2100
Education & Training
Yale-New Haven Medical CenterFellowship, Hematology and Medical Oncology, 2013 - 2016
Boston University Medical CenterChief Residency, Internal Medicine, 2011 - 2012- Boston University Medical CenterResidency, Internal Medicine, 2008 - 2011
Rutgers New Jersey Medical SchoolClass of 2008
University of PennsylvaniaBS, Economics / Biochemistry, 2000 - 2004
Certifications & Licensure
MA State Medical License 2011 - 2024
Publications & Presentations
PubMed
- 44 citationsMelphalan, lenalidomide and dexamethasone for the treatment of immunoglobulin light chain amyloidosis: results of a phase II trialSanchorawala, Jaymin M. Patel, John Mark Sloan, Anthony C Shelton, Jerome B. Zeldis
Haematologica. 2013-05-01 - 222 citationsAssociation of clinical factors and recent anticancer therapy with COVID-19 severity among patients with cancer: a report from the COVID-19 and Cancer Consortium.Petros Grivas, Ali Raza Khaki, Trisha Wise-Draper, Benjamin French, C. Hennessy
Annals of Oncology. 2021-06-01 - 20 citationsA Systematic Framework to Rapidly Obtain Data on Patients with Cancer and COVID-19: CCC19 Governance, Protocol, and Quality Assurance.Maheen Z. Abidi, David M. Aboulafia, Melissa K. Accordino, Jared D. Acoba, Manmeet Ahluwalia
Cancer Cell. 2020-12-14
Press Mentions
- CDK 4/6 Inhibitor, Ribociclib, with Adjuvant Endocrine Therapy for ER-Positive Breast Cancer (LEADER)September 18th, 2017
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
